Losartan for Improved Vascular Endothelial Function After Preeclampsia

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 22, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

March 13, 2025

Conditions

Preeclampsia Postpartum

Interventions

DRUG

Losartan Potassium

subjects ingest 50mg losartan potassium tablet daily for 6 weeks

DRUG

Placebo

subjects ingest placebo tablet daily for 6 weeks

Trial Locations (1)

University of Iowa, Iowa City

All Listed Sponsors

lead

Anna Stanhewicz, PhD

OTHER

NCT04632589 - Losartan for Improved Vascular Endothelial Function After Preeclampsia | Biotech Hunter | Biotech Hunter